Celastrol |
|
Triterpenoid |
|
Rheumatoid arthritis (RA) model: adjuvant arthritis (AA) rats |
1 mg/kg/d |
[113] |
|
RA model: antigen-induced arthritis (AIA) mice |
3 g/kg/d |
[114] |
2D and 3D model of psoriasis |
|
3, 10, 30 or 90 ng/mL |
[115] |
Glycyrrhizin |
|
Triterpenoid Saponin |
|
RA model: collagen-induced arthritis (CIA) rats |
|
[116] |
Artemisinin |
|
Sesquiterpene Lactones |
|
RA model: CIA mice |
5–20 mg/kg/d |
[117] |
|
Systemic lupus erythematosus (SLE) model: MRL/lpr mice |
|
[118] |
human umbilical vein endothelial cells (HUVECs) |
|
5 or 20 µM |
[119] |
peripheral blood mononuclear cells (PBMCs) from SLE patients |
|
5 or 20 µM |
[119] |
Spleen cells from MRL/lpr mice |
|
0.1–10 µM |
[120] |
|
SLE model: pristine-induced mouse |
100 mg/kg/d |
[121] |
|
Acute lung injury (ALI) model: lipopolysacchaide-induced ALI mice |
75 mg/kg |
[122] |
|
Asthma model: OVA-induced asthma mice |
50 mg/kg |
[123] |
Sophocarpine |
|
Alkaloid |
Fibroblast-like synoviocytes (FLSs) |
RA model: CIA mice |
|
[124] |
|
SLE model: MRL/lpr mice |
100 mg/kg/d |
[125] |
|
Asthma model: OVA-induced asthma mice |
|
[126] |
Berberine |
|
Alkaloid |
|
Autoimmune hepatitis (AIH) model: Concanavalin-A-induced AIH mice |
100 or 200 mg/kg |
[127] |
|
Guillain-Narré syndrome model: experimental autoimmune neuritis rats |
20 or 130 mg/kg/d |
[128] |
|
Myocarditis model: experimental autoimmune myocarditis (EAM) rats |
200 mg/kg/d BBR |
[129] |
Demethylenebeberine |
|
|
Multiple sclerosis (MS) model: experimental autoimmune encephalomyelitis (EAE) mice |
200 mg/kg/d |
[130] |
|
AIH model: Concanavalin-A-induced AIH mice |
|
[131] |
|
Inflammatory bowel disease model: dextran-sulfate-sodium-induced inflammatory colitis mice |
150 or 300 mg/kg |
[132] |
Betulin |
|
Pentacyclic Triterpen |
|
AIH model: Concanavalin-A-induced AIH mice |
10 or 20 mg/kg |
[133] |
|
Ulcerative colitis (UC) model: acetic-acid-induced UC rats |
8 mg/kg |
[134] |
Curvularin |
|
Macrocyclic Lactone |
Murine macrophages cell line RAW 264.7 |
|
|
[135] |
Hepatocarcinoma cell line HepG2 and breast carcinoma cell line MDA-MB-231 |
|
17.1–171 µM |
[136] |
human chondrocyte cell line C28/I2 |
RA model: CIA mice |
10 mg/kg |
[137] |
Oxacyclododecindione |
|
Macrocyclic Lactone |
Hepatocarcinoma cell line HepG2 and breast carcinoma cell line MDA-MB-231 |
|
86–1350 nM |
[136] |
|
SLE model: MRL/lpr mice |
1 mg/kg |
[138] |